|
Takeda, Teva Reach Settlement on Generic Actos, Actoplus Met
Takeda Pharmaceuticals and Teva Pharmaceutical Industries have settled their patent-infringement lawsuit over the diabetes treatments Actos and Actoplus Met, paving the way for Teva to bring generic versions of the drugs to the market in 2012.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives